Integra LifeSciences Holdings Beheer
Beheer criteriumcontroles 4/4
De CEO Integra LifeSciences Holdings is Jan De Witte, benoemd in Dec2021, heeft een ambtstermijn van 2.92 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 6.39M, bestaande uit 13.7% salaris en 86.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.031% van de aandelen van het bedrijf, ter waarde $ 549.82K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.6 jaar en 11.5 jaar.
Belangrijke informatie
Jan De Witte
Algemeen directeur
US$6.4m
Totale compensatie
| Percentage CEO-salaris | 13.7% |
| Dienstverband CEO | 2.9yrs |
| Eigendom CEO | 0.03% |
| Management gemiddelde ambtstermijn | 3.6yrs |
| Gemiddelde ambtstermijn bestuur | 11.5yrs |
Recente managementupdates
Recent updates
There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise
Nov 05
Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Oct 24Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S
Sep 08Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?
Aug 21At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?
Jul 01Integra LifeSciences Still Underperforming As Manufacturing Issues Linger
Jun 21Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price
May 28Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$7m |
| Jun 30 2024 | n/a | n/a | US$24m |
| Mar 31 2024 | n/a | n/a | US$40m |
| Dec 31 2023 | US$6m | US$875k | US$68m |
| Sep 30 2023 | n/a | n/a | US$101m |
| Jun 30 2023 | n/a | n/a | US$131m |
| Mar 31 2023 | n/a | n/a | US$172m |
| Dec 31 2022 | US$9m | US$850k | US$181m |
| Sep 30 2022 | n/a | n/a | US$173m |
| Jun 30 2022 | n/a | n/a | US$166m |
| Mar 31 2022 | n/a | n/a | US$157m |
| Dec 31 2021 | US$899k | US$59k | US$169m |
Compensatie versus markt: De totale vergoeding ($USD 6.39M ) Jan } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.43M ).
Compensatie versus inkomsten: De vergoeding van Jan is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Jan De Witte (60 yo)
2.9yrs
Tenure
US$6,388,756
Compensatie
Mr. Jan De Witte has been President, Chief Executive Officer & Director of Integra LifeSciences Holdings Corporation since December 1, 2021. He had been the Chief Executive Officer at Barco NV since Septem...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 26.9yrs | US$422.52k | 2.27% $ 40.3m | |
| President | 2.9yrs | US$6.39m | 0.031% $ 549.8k | |
| Executive VP & CFO | 1.4yrs | US$1.67m | 0.054% $ 964.6k | |
| Senior VP of Finance & Principal Accounting Officer | 7.1yrs | US$1.25m | 0.047% $ 830.1k | |
| Executive VP | 6yrs | US$1.62m | 0.082% $ 1.5m | |
| Executive VP & President of Tissue Technologies | 11.9yrs | US$1.42m | 0.084% $ 1.5m | |
| Executive VP & President of Codman Specialty Surgical | 4.5yrs | US$2.83m | 0.075% $ 1.3m | |
| Corporate VP of Global Operations & Supply Chain | 4.3yrs | geen gegevens | geen gegevens | |
| Vice President of Global Corporate Communications & Public Relations | no data | geen gegevens | geen gegevens | |
| Vice President of Global Marketing | no data | geen gegevens | geen gegevens | |
| Executive VP & Chief Human Resources Officer | 1.8yrs | geen gegevens | 0.032% $ 560.6k | |
| Corporate VP & Chief Digital Officer | 2.8yrs | geen gegevens | geen gegevens |
3.6yrs
Gemiddelde duur
57yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van IART wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.6 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 26.9yrs | US$422.52k | 2.27% $ 40.3m | |
| President | 2.9yrs | US$6.39m | 0.031% $ 549.8k | |
| Independent Director | 15.6yrs | US$297.54k | 0.11% $ 1.9m | |
| Independent Director | 18.8yrs | US$293.28k | 0.082% $ 1.5m | |
| Independent Presiding Director | 11.5yrs | US$342.54k | 0.18% $ 3.1m | |
| Independent Director | 32.8yrs | US$306.31k | 0.091% $ 1.6m | |
| Independent Director | less than a year | US$90.68k | 0.016% $ 287.3k | |
| Independent Director | 3.6yrs | US$260.04k | 0.028% $ 504.2k | |
| Independent Director | 2.3yrs | US$297.54k | 0.021% $ 371.5k |
11.5yrs
Gemiddelde duur
63yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van IART zijn ervaren en ervaren (gemiddelde ambtstermijn van 11.5 jaar).